advertisement
Konstas AG 126
Showing records 1 to 25 | Display only abstracts from Konstas AG in IGR 16-4104564 Evaluation of a Novel Αb Εxterno MicroShunt for the Treatment of Glaucoma
Burgos-Blasco B; García-Feijóo J; Perucho-Gonzalez L; Güemes-Villahoz N; Morales-Fernandez L; Mendez-Hernández CD; Martinez De La Casa JM; Konstas AG
Advances in Therapy 2022; 39: 3916-3932 (IGR: 23-2)
96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Katsanos A; Riva I; Bozkurt B; Holló G; Quaranta L; Oddone F; Irkec M; Dutton GN; Konstas AG
Expert Opinion on Drug Safety 2021; 0: 1-15 (IGR: 22-3)
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Konstas AG
Advances in Therapy 2021; 38: 24-51 (IGR: 21-4)
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Konstas AG; Labbé A
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Schmetterer L
Advances in Therapy 2021; 38: 24-51 (IGR: 21-4)
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Katsanos A
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Katsanos A
Advances in Therapy 2021; 38: 24-51 (IGR: 21-4)
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Meier-Gibbons F
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Hutnik CML; Holló G
Advances in Therapy 2021; 38: 24-51 (IGR: 21-4)
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Irkec M
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Quaranta L
Advances in Therapy 2021; 38: 24-51 (IGR: 21-4)
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Boboridis KG
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Teus MA
Advances in Therapy 2021; 38: 24-51 (IGR: 21-4)
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Holló G; García-Feijoo J
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Uusitalo H; Pfeiffer N
Advances in Therapy 2021; 38: 24-51 (IGR: 21-4)
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Dutton GN
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)
91764 Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
Katz LJ
Advances in Therapy 2021; 38: 24-51 (IGR: 21-4)
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Baudouin C
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)
84728 Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review
Occhiutto ML; Maranhão RC; Costa VP; Konstas AG
Advances in Therapy 2020; 37: 155-199 (IGR: 21-1)
80961 Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients
Riva I; Legramandi L; Rulli E; Konstas AG; Katsanos A; Oddone F; Weinreb RN; Quaranta L;
Scientific reports 2019; 9: 6735 (IGR: 20-3)
79424 Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options
Dastiridou AI; Katsanos A; Denis P; Francis BA; Mikropoulos DG; Teus MA; Konstas AG
Advances in Therapy 2018; 35: 2103-2127 (IGR: 20-2)
79188 Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment
Konstas AG
Advances in Therapy 2018; 35: 1775-1804 (IGR: 20-1)
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Konstas AG; Katsanos A
Expert Opinion in Pharmacotherapy 2018; 0: 1-8 (IGR: 20-1)
79188 Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment
Kahook MY
Advances in Therapy 2018; 35: 1775-1804 (IGR: 20-1)
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Athanasopoulos GP
Expert Opinion in Pharmacotherapy 2018; 0: 1-8 (IGR: 20-1)
